Market Tracker

05/22 6:01pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

12.56
Delayed Data
As of May 22
 +0.10 / +0.80%
Today’s Change
5.53
Today|||52-Week Range
13.84
+11.15%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close12.46
Today’s open12.46
Day’s range12.38 - 12.69
Volume584,437
Average volume (3 months)1,372,792
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-37.50%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc-0.15-0.66%
ACORAcorda Therapeutics ...-0.25-0.77%
RGENRepligen Corp-0.31-0.75%
ZSPHZS Pharma Inc+1.44+2.55%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts